Mitral regurgitation pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 46: Line 46:
In the acute setting, the stroke volume of the left ventricle is increased (increased [[ejection fraction]]), but the forward cardiac output is decreased.  The mechanism by which the total stroke volume is increased is known as the [[Frank-Starling law of the heart|Frank-Starling mechanism]].
In the acute setting, the stroke volume of the left ventricle is increased (increased [[ejection fraction]]), but the forward cardiac output is decreased.  The mechanism by which the total stroke volume is increased is known as the [[Frank-Starling law of the heart|Frank-Starling mechanism]].


The regurgitant volume causes a volume overload and a pressure overload of the [[left atrium]].  The increased pressures in the left atrium inhibit drainage of blood from the lungs via the [[pulmonary vein]]s.  This causes [[congestive heart failure|pulmonary congestion]].
The regurgitant volume causes a volume overload and a pressure overload of the [[left atrium]] as shown in graph below.  The increased pressures in the left atrium inhibit drainage of blood from the lungs via the [[pulmonary vein]]s.  This causes [[congestive heart failure|pulmonary congestion]].
 
[[Image:MR pressure graph.jpg]]


===Chronic compensated phase===
===Chronic compensated phase===

Revision as of 01:13, 23 March 2011

Mitral regurgitation (schematic drawing)
During systole, contraction of the left ventricle causes abnormal backflow (arrow) into the left atrium.
1 Mitral valve
2 Left Ventricle
3 Left Atrium
4 Aorta

WikiDoc Resources for Mitral regurgitation pathophysiology

Articles

Most recent articles on Mitral regurgitation pathophysiology

Most cited articles on Mitral regurgitation pathophysiology

Review articles on Mitral regurgitation pathophysiology

Articles on Mitral regurgitation pathophysiology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitral regurgitation pathophysiology

Images of Mitral regurgitation pathophysiology

Photos of Mitral regurgitation pathophysiology

Podcasts & MP3s on Mitral regurgitation pathophysiology

Videos on Mitral regurgitation pathophysiology

Evidence Based Medicine

Cochrane Collaboration on Mitral regurgitation pathophysiology

Bandolier on Mitral regurgitation pathophysiology

TRIP on Mitral regurgitation pathophysiology

Clinical Trials

Ongoing Trials on Mitral regurgitation pathophysiology at Clinical Trials.gov

Trial results on Mitral regurgitation pathophysiology

Clinical Trials on Mitral regurgitation pathophysiology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitral regurgitation pathophysiology

NICE Guidance on Mitral regurgitation pathophysiology

NHS PRODIGY Guidance

FDA on Mitral regurgitation pathophysiology

CDC on Mitral regurgitation pathophysiology

Books

Books on Mitral regurgitation pathophysiology

News

Mitral regurgitation pathophysiology in the news

Be alerted to news on Mitral regurgitation pathophysiology

News trends on Mitral regurgitation pathophysiology

Commentary

Blogs on Mitral regurgitation pathophysiology

Definitions

Definitions of Mitral regurgitation pathophysiology

Patient Resources / Community

Patient resources on Mitral regurgitation pathophysiology

Discussion groups on Mitral regurgitation pathophysiology

Patient Handouts on Mitral regurgitation pathophysiology

Directions to Hospitals Treating Mitral regurgitation pathophysiology

Risk calculators and risk factors for Mitral regurgitation pathophysiology

Healthcare Provider Resources

Symptoms of Mitral regurgitation pathophysiology

Causes & Risk Factors for Mitral regurgitation pathophysiology

Diagnostic studies for Mitral regurgitation pathophysiology

Treatment of Mitral regurgitation pathophysiology

Continuing Medical Education (CME)

CME Programs on Mitral regurgitation pathophysiology

International

Mitral regurgitation pathophysiology en Espanol

Mitral regurgitation pathophysiology en Francais

Business

Mitral regurgitation pathophysiology in the Marketplace

Patents on Mitral regurgitation pathophysiology

Experimental / Informatics

List of terms related to Mitral regurgitation pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S. ; Lakshmi Gopalakrishnan, M.B.B.S.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mechanical Basis of Mitral Regurgitation

The mitral valve is composed of the valve leaflets, the mitral valve annulus (which forms a ring around the valve leaflets), the papillary muscles (which tether the valve leaflets to the left ventricle, preventing them from prolapsing into the left atrium), and the chordae tendineae (which connect the valve leaflets to the papillary muscles). A dysfunction of any of these portions of the mitral valve apparatus can cause mitral regurgitation. The underlying mechanical mechanisms underlying mitral regurgitation include the following:

  • Anterior Leaflet Prolapse
  • Posterior Leaflet Prolapse
  • Bileaflet Prolapse
  • Restricted Leaflets
  • Apical Tethering
  • Papillary muscle rupture
  • Ischemic Papillary Rupture
  • Leaflet Perforation

Diseases Causing Mitral Regurgitation

Primary mitral regurgitation is due to any disease process that affects the mitral valve apparatus itself. The causes of primary mitral regurgitation include:

Secondary mitral regurgitation is due to the dilatation of the left ventricle, causing stretching of the mitral valve annulus and displacement of the papillary muscles. This dilatation of the left ventricle can be due to any cause of dilated cardiomyopathy, including aortic insufficiency, nonischemic dilated cardiomyopathy and Noncompaction Cardiomyopathy.

The Three Phases in the Pathophysiology of Mitral Regurgitation

The pathophysiology of mitral regurgitation can be divided into three phases of the disease process:

Acute phase

Acute mitral regurgitation (as may occur due to the sudden rupture of a chordae tendineae or papillary muscle) causes a sudden volume overload of both the left atrium and the left ventricle.

The left ventricle develops volume overload because with every contraction it now has to pump out not only the volume of blood that goes into the aorta (the forward cardiac output or forward stroke volume), but also the blood that regurgitates into the left atrium (the regurgitant volume).

The combination of the forward stroke volume and the regurgitant volume is known as the total stroke volume of the left ventricle.

In the acute setting, the stroke volume of the left ventricle is increased (increased ejection fraction), but the forward cardiac output is decreased. The mechanism by which the total stroke volume is increased is known as the Frank-Starling mechanism.

The regurgitant volume causes a volume overload and a pressure overload of the left atrium as shown in graph below. The increased pressures in the left atrium inhibit drainage of blood from the lungs via the pulmonary veins. This causes pulmonary congestion.

Chronic compensated phase

If the mitral regurgitation develops slowly over months to years or if the acute phase can be managed with medical therapy, the individual will enter the chronic compensated phase of the disease. In this phase, the left ventricle develops eccentric hypertrophy in order to better manage the larger than normal stroke volume.

The eccentric hypertrophy and the increased diastolic volume combine to increase the stroke volume (to levels well above normal) so that the forward stroke volume (forward cardiac output) approaches the normal levels.

In the left atrium, the volume overload causes enlargement of the chamber of the left atrium, allowing the filling pressure in the left atrium to decrease. This improves the drainage from the pulmonary veins, and signs and symptoms of pulmonary congestion will decrease.

These changes in the left ventricle and left atrium improve the low forward cardiac output state and the pulmonary congestion that occur in the acute phase of the disease. Individuals in the chronic compensated phase may be asymptomatic and have normal exercise tolerances.

Chronic decompensated phase

An individual may be in the compensated phase of mitral regurgitation for years, but will eventually develop left ventricular dysfunction, the hallmark for the chronic decompensated phase of mitral regurgitation. It is currently unclear what causes an individual to enter the decompensated phase of this disease. However, the decompensated phase is characterized by calcium overload within the cardiac myocytes.

In this phase, the ventricular myocardium is no longer able to contract adequately to compensate for the volume overload of mitral regurgitation, and the stroke volume of the left ventricle will decrease. The decreased stroke volume causes a decreased forward cardiac output and an increase in the end-systolic volume. The increased end-systolic volume translates to increased filling pressures of the ventricular and increased pulmonary venous congestion. The individual may again have symptoms of congestive heart failure.

The left ventricle begins to dilate during this phase. This causes a dilatation of the mitral valve annulus, which may worsen the degree of mitral regurgitation. The dilated left ventricle causes an increase in the wall stress of the cardiac chamber as well.

While the ejection fraction is less in the chronic decompensated phase than in the acute phase or the chronic compensated phase of mitral regurgitation, it may still be in the normal range (i.e: > 50 percent), and may not decrease until late in the disease course. A decreased ejection fraction in an individual with mitral regurgitation and no other cardiac abnormality should alert the physician that the disease may be in its decompensated phase.

Summary: Distinguishing the Three Phases of Mitral Regurgitation

Comparison of acute and chronic mitral regurgitation
Acute mitral regurgitation Chronic mitral regurgitation
ElectrocardiogramNormalP mitrale, atrial fibrillation, left ventricular hypertrophy
Heart sizeNormalCardiomegaly, left atrial enlargement
Systolic murmurHeard at the base, radiates to the neck, spine, or top of headHeard at the apex, radiates to the axilla
Apical thrillMay be absentPresent
Jugular venous distensionPresentAbsent

References

Template:WH Template:WS